Haas 2016.

Study characteristics
Methods	Randomised trial, USA.
Participants	117 patients with cancer beginning chemo, hormone, or radio therapy.
Interventions	Assessment of symptoms using the FACT‐G bi‐weekly with feedback to clinical team vs usual care.    Intervention features Multiple simple feedback (one PROM at multiple times) PROM(s) used as intervention: SymptomCareAnywhere (SCA)  Constructs measured: Symptoms Instrument categories/domains: Domain/Disease specific (Cancer)   Administration features Where PROMs administered: Non‐clinical setting How administered: Self‐administered Format of PROMs questionnaire(s): Electronic   Feedback features Format of PROMs feedback: Electronic How often information fed back: At lease weekly Who information fed back to: Clinicians, Patients Information fed back: Scores, Previous scores, Interpretation guidance, Management recommendations
Outcomes	Main outcome: FACT‐G scores.
Notes	Funding source not reported. The study period was not reported. Conflicts of interest were not reported.
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Unclear risk	Not reported ‐ abstract only.
Allocation concealment (selection bias)	Unclear risk	Not reported ‐ abstract only.
Blinding of participants and personnel (performance bias) All outcomes	Unclear risk	Not reported ‐ abstract only.
Blinding of outcome assessment (detection bias) All outcomes	Unclear risk	Not reported ‐ abstract only.
Baseline outcome measurements similar	Unclear risk	Not reported ‐ abstract only.
Baseline characteristics similar	Unclear risk	Not reported ‐ abstract only.
Incomplete outcome data (attrition bias) All outcomes	High risk	Only regular users of the interventions were included in the analysis (22 of 51 randomised).
Was study protected against contamination	Unclear risk	Not reported ‐ abstract only.
Selective reporting (reporting bias)	Unclear risk	Not reported.